Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $131B |
| FY2017, ended Dec 31, 2017 | $136B |
| FY2018, ended Dec 31, 2018 | $92.6B |
| FY2019, ended Dec 31, 2019 | $92.8B |
| FY2020, ended Dec 31, 2020 | $76.2B |
| FY2021, ended Dec 31, 2021 | $86.1B |
| FY2022, ended Dec 31, 2022 | $81.6B |
| FY2023, ended Dec 31, 2023 | $71.1B |
| FY2024, ended Dec 31, 2024 | $88.4B |
| FY2025, ended Dec 31, 2025 | $96.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $120B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.7B |
| FY2017, ended Dec 31, 2017 | $25.6B |
| FY2018, ended Dec 31, 2018 | $25.4B |
| FY2019, ended Dec 31, 2019 | $25.1B |
| FY2020, ended Dec 31, 2020 | $26.2B |
| FY2021, ended Dec 31, 2021 | $26.0B |
| FY2022, ended Dec 31, 2022 | $25.1B |
| FY2023, ended Dec 31, 2023 | $24.5B |
| FY2024, ended Dec 31, 2024 | $24.0B |
| FY2025, ended Dec 31, 2025 | $23.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $23.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $14.2B | $3.64B |
| FY2017, ended Dec 31, 2017 | $10.2B | $4.70B |
| FY2018, ended Dec 31, 2018 | $6.96B | $8.15B |
| FY2019, ended Dec 31, 2019 | −$1.29B | $7.59B |
| FY2020, ended Dec 31, 2020 | $4.47B | $8.15B |
| FY2021, ended Dec 31, 2021 | $2.48B | $8.24B |
| FY2022, ended Dec 31, 2022 | $5.76B | $8.05B |
| FY2023, ended Dec 31, 2023 | $8.13B | $9.09B |
| FY2024, ended Dec 31, 2024 | $11.3B | $8.61B |
| FY2025, ended Dec 31, 2025 | $6.95B | $9.07B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $7.97B | $9.11B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.57B |
| FY2017, ended Dec 31, 2017 | $1.25B |
| FY2018, ended Dec 31, 2018 | $1.33B |
| FY2019, ended Dec 31, 2019 | $2.12B |
| FY2020, ended Dec 31, 2020 | $4.95B |
| FY2021, ended Dec 31, 2021 | $4.54B |
| FY2022, ended Dec 31, 2022 | $4.03B |
| FY2023, ended Dec 31, 2023 | $3.69B |
| FY2024, ended Dec 31, 2024 | $3.13B |
| FY2025, ended Dec 31, 2025 | $4.47B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.37B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $13.9B |
| FY2017, ended Dec 31, 2017 | $13.9B |
| FY2018, ended Dec 31, 2018 | $25.7B |
| FY2019, ended Dec 31, 2019 | $28.0B |
| FY2020, ended Dec 31, 2020 | $29.5B |
| FY2021, ended Dec 31, 2021 | $28.0B |
| FY2022, ended Dec 31, 2022 | $26.7B |
| FY2023, ended Dec 31, 2023 | $26.2B |
| FY2024, ended Dec 31, 2024 | $24.9B |
| FY2025, ended Dec 31, 2025 | $25.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $24.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.94B |
| FY2017, ended Dec 31, 2017 | 1.90B |
| FY2018, ended Dec 31, 2018 | 1.87B |
| FY2019, ended Dec 31, 2019 | 1.86B |
| FY2020, ended Dec 31, 2020 | 1.86B |
| FY2021, ended Dec 31, 2021 | 1.82B |
| FY2022, ended Dec 31, 2022 | 1.79B |
| FY2023, ended Dec 31, 2023 | 1.76B |
| FY2024, ended Dec 31, 2024 | 1.69B |
| FY2025, ended Dec 31, 2025 | 1.67B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.67B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.03B |
| FY2017, ended Dec 31, 2017 | $2.92B |
| FY2018, ended Dec 31, 2018 | $1.67B |
| FY2019, ended Dec 31, 2019 | $845M |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | $1.68B |
| FY2022, ended Dec 31, 2022 | $1.82B |
| FY2023, ended Dec 31, 2023 | $1.00B |
| FY2024, ended Dec 31, 2024 | $3.40B |
| FY2025, ended Dec 31, 2025 | $1.00B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $735M |
Valuation
At current price- Market Cap
- $123B
- P/E
- 15.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.2×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 12.9×
Growth
Trailing 12 months- Revenue (TTM)
- $23.5B
- Revenue Growth YoY
- −0.6%
- Revenue CAGR 3Y
- −2.5%
- Revenue CAGR 5Y
- −2.3%
- EPS Growth YoY
- −8.1%
- Net Income Growth YoY
- −9.3%
Profitability
Trailing 12 months- Gross Margin
- 63.0%
- Operating Margin
- 46.8%
- Net Margin
- 34.0%
- FCF Margin
- 38.8%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $7.97B
- EPS (diluted)
- $4.75
- EBITDA
- $11.2B
- Operating Income
- $11.0B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.37B
- Total Debt
- $24.6B
- Net Debt
- $22.2B
- Total Assets
- $33.4B
- Total Liabilities
- $36.0B
- Shareholders' Equity
- −$2.67B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.41B
- Capital Expenditure
- $296M
- Free Cash Flow
- $9.11B
Dividends and risk
Last 12 months- Dividend Yield
- 5.8%
- Dividend / Share
- $4.29
- Beta (5Y)
- 0.43
Every ratio is calculated from the company’s reported figures.